Health
Novavax and Serum Institute of India Announce Submission to Regulatory Agencies in India, Indonesia, Philippines for Emergency Use Authorization of Novavax’ Recombinant Nanoparticle COVID-19 Vaccine – The Korea Herald
– Novavax and Serum Institute of India file regulatory submissions to the Drugs Controller General of India and to regulatory…
– Novavax and Serum Institute of India file regulatory submissions to the Drugs Controller General of India and to regulatory agencies in Indonesia and Philippines for Novavax’ recombinant nanoparticle COVID-19 vaccine
– Filing for World Health Organization…
Continue Reading
-
Noosa News12 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
General21 hours agoProductivity summit ends day two with progress on rules changes to boost housing supply
-
Business17 hours agoAre BHP shares are buy after its results?
-
Business8 hours agoWhere next for the CBA share price?